Article Text

Download PDFPDF
Extended report
Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis
  1. T R D J Radstake1,
  2. M Svenson2,
  3. A M Eijsbouts3,
  4. F H J van den Hoogen3,
  5. C Enevold2,
  6. P L C M van Riel1,
  7. K Bendtzen2
  1. 1
    Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
  2. 2
    Institute for Inflammation Research (IIR), Rigshospitalet National University Hospital Copenhagen, Denmark, and BioMonitor A/S, Symbion Science Park, Copenhagen, Denmark
  3. 3
    Department of Rheumatology, St Maartenskliniek, Nijmegen, The Netherlands
  1. Correspondence to Dr T R D J Radstake, Department of Rheumatology, Radboud University Nijmegen Medical Centre, Geert Grooteplein 8, 6500 HB Nijmegen, The Netherlands; T.Radstake{at}reuma.umcn.nl

Footnotes

  • Funding The study was partly funded by Abbott Immunology Inc, Chicago, USA.

  • Competing interests None.

  • Ethics approval Approval from the local ethics committee.

  • Abbott Inc did not have any influence on the set-up of the study, the interpretation of the data or the writing of the paper.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Funding The study was partly funded by Abbott Immunology Inc, Chicago, USA.

  • Competing interests None.

  • Ethics approval Approval from the local ethics committee.

  • Abbott Inc did not have any influence on the set-up of the study, the interpretation of the data or the writing of the paper.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.